{"schema_version":"1","generated_at":"2026-11-03T12:19:50.526Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kimo-bachiashvili","json_url":"https://www.findmykol.com/kol/kimo-bachiashvili/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kimo-bachiashvili","name":"Kimo Bachiashvili","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1154683266","openalex":"A5022965758"},"summary":"Kimo Bachiashvili is an Oncology physician. OpenAlex indexes 69 publications with 469 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":69,"cited_by_count":469,"h_index":10,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"AbbVie Inc.","program_year":2023,"amount_usd":14.6,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154683266"},{"payer":"ABBVIE INC.","program_year":2022,"amount_usd":34.89,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154683266"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1154683266","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":37.3,"classes_total":5,"classes":[{"class":"Calcineurin inhibitor","setting":"prescribed","share_pct":11.5,"drugs":[{"name":"Cyclosporine Modified","share_pct":100}],"max_beneficiaries":11},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":11.2,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":18}]},{"area":"Dermatology","share_pct":19.2,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":19.2,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":30}]},{"area":"Anti-infectives","share_pct":16.7,"classes_total":2,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":8.8,"drugs":[{"name":"Posaconazole","share_pct":56.5},{"name":"Voriconazole","share_pct":43.5}],"max_beneficiaries":null},{"class":"Fluoroquinolone Antibacterial","setting":"prescribed","share_pct":7.9,"drugs":[{"name":"Levofloxacin","share_pct":100}],"max_beneficiaries":19}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":4.9,"facility_pct":95.1},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia","year":2026,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers18111831","status":"verified"},{"title":"Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis","year":2026,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-026-72963-y","status":"verified"},{"title":"Real-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia","year":2025,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers17132148","status":"verified"},{"title":"Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes","year":2025,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci189266","status":"verified"},{"title":"Outcomes with intensive chemotherapy, compared to hypomethylating agent + venetoclax, in patients with intermediate and adverse risk acute myeloid leukemia","year":2025,"journal":"Leukemia Research","source_url":"https://doi.org/10.1016/j.leukres.2025.107920","status":"verified"}],"source":"works"},"contact":{"address_1":"2000 6TH AVE S","city":"Birmingham","state":"AL","zip":"35233","phone":"205-934-9999","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1154683266","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-06-30","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}